Professional Title & Qualifications:
Chief Physician
Specialization:
Hospital & Department：
Shanghai Renji Hospital, Jiao Tong University – Department of Obstetrics and Gynecology
Dr. Jun Ma - Obstetrics and Gynecology Specialist
Personal Biography
Dr. Jun Ma is a Chief Physician in the Department of Obstetrics and Gynecology at Renji Hospital, affiliated with the Shanghai Jiao Tong University School of Medicine. His work focuses on both benign and malignant gynecological conditions, with a strong emphasis on advanced surgical techniques and clinical research. Dr. Ma is a published researcher specializing in gynecologic oncology, particularly epithelial ovarian cancer and fallopian tube carcinoma. His research also explores the application of advanced minimally invasive procedures, such as laparoendoscopic single-site surgery (LESS), and the use of artificial intelligence and biomarkers in predicting surgical outcomes and patient prognosis.
Book an online consultation with Dr. Jun Ma
Areas of Expertise
-
Gynecologic Oncology
-
Epithelial Ovarian Cancer
-
Peritoneal Metastasis
-
Fallopian Tube Carcinoma
-
Benign Gynecological Diseases
-
Minimally Invasive Gynecologic Surgery
-
Laparoendoscopic Single-Site Surgery (LESS)
Clinical Highlights
-
Over 1,000 patients treated
-
100% treatment satisfaction rate
-
100% patient satisfaction with service attitude
Work Experience
-
Currently serves as a Chief Physician at the Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine.
Research Achievements
-
Investigating prognostic factors and biomarkers for epithelial ovarian cancer (EOC), such as plasma fibrinogen and neutrophil-lymphocyte ratio (F-NLR).
-
Developing prediction models using machine learning and artificial intelligence to assess surgical outcomes and prognosis in gynecologic patients.
-
Analyzing the learning curve and application of laparoendoscopic single-site surgery (LESS) for benign gynecological diseases.
-
Exploring the molecular mechanisms of ovarian cancer progression, including the role of reactive oxygen species (ROS) and tumor-associated macrophages (TAMs).
-
Case studies and literature reviews on rare conditions, such as primary neuroendocrine carcinoma of the fallopian tube.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.